Experimental data suggest the
antimicrobial peptide hepcidin as a central regulator in
iron homeostasis. In this study, we characterized the expression of human
hepcidin in experimental and clinical
iron overload conditions, including hereditary
hemochromatosis. Using quantitative
reverse transcriptase-polymerase chain reaction (RT-PCR), we determined expression of
hepcidin and the most relevant
iron-related genes in liver biopsies from patients with
hemochromatosis and
iron-
stain-negative control subjects. Regulation of
hepcidin mRNA expression in response to
transferrin-bound
iron, non-
transferrin-bound
iron, and
deferoxamine was analyzed in HepG2 cells.
Hepcidin expression correlated significantly with serum
ferritin levels in controls, whereas no significant up-regulation was observed in patients with
hemochromatosis despite
iron-overload conditions and high serum
ferritin levels. However, patients with
hemochromatosis showed an inverse correlation between
hepcidin transcript levels and the serum
transferrin saturation. Moreover, we found a significant correlation between hepatic transcript levels of
hepcidin and
transferrin receptor-2 irrespective of the
iron status. In vitro data indicated that
hepcidin expression is down-regulated in response to non-
transferrin-bound
iron. In conclusion, the presented data suggest a close relationship between the
transferrin saturation and hepatic
hepcidin expression in hereditary
hemochromatosis. Although the causality is not yet clear, this interaction might result from a down-regulation of
hepcidin expression in response to significant levels of non-
transferrin-bound
iron.